Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 12:44 AM
Study NCT ID:
NCT00140660
Status:
TERMINATED
Last Update Posted:
2017-03-13
First Post:
2005-08-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma
Sponsor:
Lymphoma Study Association
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-12
Start Date Type:
ACTUAL
Primary Completion Date:
2008-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-31
First Submit QC Date:
None
Study First Post Date:
2005-09-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-09
Last Update Post Date:
2017-03-13
Last Update Post Date Type:
ACTUAL